Company
Respiree
Data-driven Healthcare Transformations
- Status
- Operatingas of 2026-09-23Source (opens in a new tab)
- Business model
- B2B
- Customers
- leading healthcare systems, medical technology companies, biopharma and patients
Record updated 28 September 2026
About
Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated artificial intelligence (AI) for managing disease progression across healthcare's care continuum. The 1Bio™ platform by Respiree™ uses data from the EHR and its proprietary US-patented and FDA-cleared sensors to longitudinal measure and track disease progression. Respiree™ is now available in U.S., Australia and Asia-Pacific (APAC). Respiree™ is CE marked, has received regulatory clearances in Australia from the Therapeutics Goods Administration and has received the 510k clearance from the United States Food and Drug Administration (FDA).
Products
- Other
- 1Bio platform
- Web
- Respiree 1Bio
- Web
- Respiree Care